propylparaben has been researched along with pilocarpine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bruno-Blanch, L; Fernández-Mas, R; Magdaleno-Madrigal, VM; Orozco-Suárez, SA; Rocha, L; Santana-Gómez, CE; Talevi, A | 1 |
| Domínguez-Valentín, AE; Hernández-Moreno, A; Orozco-Suárez, S; Rocha, L; Santana-Gómez, CE; Valle-Dorado, MG | 1 |
3 other study(ies) available for propylparaben and pilocarpine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Propylparaben applied after pilocarpine-induced status epilepticus modifies hippocampal excitability and glutamate release in rats.
Topics: Action Potentials; Animals; Anticonvulsants; Cell Count; Diazepam; Disease Models, Animal; Electric Stimulation; Fluoresceins; Glial Fibrillary Acidic Protein; Glutamic Acid; Hippocampus; Male; Muscarinic Agonists; Parabens; Phosphopyruvate Hydratase; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus | 2017 |
Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus.
Topics: Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Hippocampus; Levetiracetam; Lithium; Male; Neurons; Neuroprotective Agents; Parabens; Pilocarpine; Rats, Wistar; Seizures; Status Epilepticus; Time | 2018 |